Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Nova Allegro HbA1c Assay, Nova Allegro Analyzer

K-Number: K221326 · 2024-11-22

Decision Date2024-11-22
Product CodeLCP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

Nova Allegro HbA1c Assay, Nova Allegro Analyzer is a medical device manufactured by Nova Biomedical Corporation. It received FDA 510(k) clearance on 2024-11-22 under approval number K221326. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Nova Allegro HbA1c Assay, Nova Allegro Analyzer?

Nova Allegro HbA1c Assay, Nova Allegro Analyzer is a medical device that received FDA 510(k) clearance on 2024-11-22. It is manufactured by Nova Biomedical Corporation. The 510(k) number is K221326.

When was Nova Allegro HbA1c Assay, Nova Allegro Analyzer approved by the FDA?

Nova Allegro HbA1c Assay, Nova Allegro Analyzer received FDA 510(k) clearance on 2024-11-22, under approval number K221326.

What company makes Nova Allegro HbA1c Assay, Nova Allegro Analyzer?

Nova Allegro HbA1c Assay, Nova Allegro Analyzer is manufactured by Nova Biomedical Corporation.

What is the FDA product code for Nova Allegro HbA1c Assay, Nova Allegro Analyzer?

The FDA product code for Nova Allegro HbA1c Assay, Nova Allegro Analyzer is LCP.

Other Devices by Nova Biomedical Corporation

View all 27 devices →

Related Devices (Code: LCP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.